Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Ruiz, Lucie"'
Autor:
Chae, Heeyoung, Augustin, Robert, Gatineau, Eva, Mayoux, Eric, Bensellam, Mohammed, Antoine, Nancy, Khattab, Firas, Lai, Bao-Khanh, Brusa, Davide, Stierstorfer, Birgit, Klein, Holger, Singh, Bilal, Ruiz, Lucie, Pieper, Michael, Mark, Michael, Herrera, Pedro L., Gribble, Fiona M., Reimann, Frank, Wojtusciszyn, Anne, Broca, Christophe, Rita, Nano, Piemonti, Lorenzo, Gilon, Patrick
Publikováno v:
In Molecular Metabolism December 2020 42
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Gilon, Patrick, Chae, Heeyoung, Antoine, Nancy, Lai, Bao Khanh, Singh, Bilal, Ruiz, Lucie, Wojtusciszyn, Anne, Broca, Christophe, Stierstorfer, Birgit, Klein, Thomas, Mayoux, Eric, Pieper, Michael, Mark, Michael, Augustin, Robert, 55th EASD Annual Meeting of the European Association for the Study of Diabetes
Publikováno v:
Diabetologia, Vol. 62, no.Suppl 1, p. S125 (2019)
BACKGROUND AND AIMS: SGLT2 inhibitors (SGLT2i), such as dapagliflozin and empagliflozin, are effective glucose-lowering medications with a unique, insulin-independent mechanism that is to promote glycosuria. SGTL2i-induced glycosuria is associated wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1493::ee6272345ac28fdcebc33297b0e7488e
https://hdl.handle.net/2078.1/230684
https://hdl.handle.net/2078.1/230684
Autor:
Ferraiolo, Mattia, Beckers, Pauline, Marquet, Nicolas, Roumain, Martin, Ruiz, Lucie, Dupuis, Nadine, Hanson, Julien, Hermans, Emmanuel
Publikováno v:
Pharmacology Research & Perspectives; Feb2021, Vol. 9 Issue 1, p1-10, 10p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ruiz, Lucie, Mathieu, Julia, Wojtusciszyn, Anne, Ravier, Magalie, Bertrand, Gyslaine, Dalle, Stéphane, Costes, Safia
Publikováno v:
In Diabetes and Metabolism March 2017 43(2) Supplement:A85-A85
Autor:
Chae, Heeyoung, Augustin, Robert, Gatineau, Eva, Mayoux, Eric, Bensellam, Mohammed, Antoine, Nancy, Khattab, Firas, Lai, Bao-Khanh, Brusa, Davide, Stierstorfer, Birgit, Klein, Holger, Singh, Bilal, Ruiz, Lucie, Pieper, Michael, Mark, Michael, Herrera, Pedro L, Gribble, Fiona M, Reimann, Frank, Wojtusciszyn, Anne, Broca, Christophe, Rita, Nano, Piemonti, Lorenzo, Gilon, Patrick
OBJECTIVE: Sodium-glucose cotransporter 2 (SGLT2) inhibitors (SGLT2i), or gliflozins, are anti-diabetic drugs that lower glycemia by promoting glucosuria, but they also stimulate endogenous glucose and ketone body production. The likely causes of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf3a47ef3e1e59ff7a03d7515fe747ff
Autor:
Nancy Antoine, Lucie Ruiz, Holger Klein, Patrick Gilon, Anne Wojtusciszyn, Fiona M. Gribble, Frank Reimann, Robert Augustin, Bao-Khanh Lai, Bilal Singh, Michael P. Pieper, Eva Gatineau, Nano Rita, Mohammed Bensellam, Pedro Luis Herrera, Birgit Stierstorfer, Firas Khattab, Heeyoung Chae, Lorenzo Piemonti, Davide Brusa, Michael Mark, Eric Mayoux, Christophe Broca
Publikováno v:
Molecular Metabolism
Molecular metabolism, vol. 42, pp. 101071
Molecular metabolism
Molecular metabolism, Elsevier, 2020, 42, pp.101071. ⟨10.1016/j.molmet.2020.101071⟩
Molecular Metabolism (2020) P. 101071
Molecular Metabolism, Vol 42, Iss, Pp 101071-(2020)
Molecular metabolism, vol. 42, pp. 101071
Molecular metabolism
Molecular metabolism, Elsevier, 2020, 42, pp.101071. ⟨10.1016/j.molmet.2020.101071⟩
Molecular Metabolism (2020) P. 101071
Molecular Metabolism, Vol 42, Iss, Pp 101071-(2020)
Objective Sodium-glucose cotransporter 2 (SGLT2) inhibitors (SGLT2i), or gliflozins, are anti-diabetic drugs that lower glycemia by promoting glucosuria, but they also stimulate endogenous glucose and ketone body production. The likely causes of thes